Vestmark Advisory Solutions’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $987K | Buy |
+63,862
| New | +$987K | 0.01% | 500 |
|
|
2024
Q4 | – | Sell |
-55,528
| Closed | -$790K | – | 608 |
|
|
2024
Q3 | $790K | Sell |
55,528
-17,205
| -24% | -$245K | 0.03% | 335 |
|
|
2024
Q2 | $941K | Buy |
72,733
+4,541
| +7% | +$58.8K | 0.04% | 318 |
|
|
2024
Q1 | $947K | Buy |
68,192
+3,272
| +5% | +$45.4K | 0.04% | 321 |
|
|
2023
Q4 | $926K | Buy |
64,920
+1,290
| +2% | +$18.4K | 0.05% | 294 |
|
|
2023
Q3 | $984K | Buy |
63,630
+870
| +1% | +$13.5K | 0.07% | 243 |
|
|
2023
Q2 | $986K | Sell |
62,760
-594
| -0.9% | -$9.33K | 0.04% | 449 |
|
|
2023
Q1 | $1.04M | Buy |
63,354
+2,698
| +4% | +$44.5K | 0.05% | 426 |
|
|
2022
Q4 | $946K | Sell |
60,656
-1,564
| -3% | -$24.4K | 0.05% | 430 |
|
|
2022
Q3 | $807K | Buy |
+62,220
| New | +$807K | 0.05% | 438 |
|